Descartes-08 not checked

Cartesian Therapeutics · Decartes-08

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
5 active
6 in total · 1 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Autogolous T-cells expressing a chimeric antigen receptor directed to BCMA”In the company’s words, NCT04146051 on ClinicalTrials.gov
Tested for
Myasthaenia Gravis, Myasthenia Gravis, Generalized, Systemic Lupus Erythematosus (SLE), Antisynthetase Syndrome, Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV), Juvenile Myasthenia Gravis, Juvenile Dermatomyositis
Main trialPhase 3
“The AURORA Study is evaluating the safety, tolerability, and efficacy of an investigational mRNA CAR T-cell therapy known as Descartes-08 in adults with acetylcholine receptor autoantibody -positive generalized myasthenia gravis. Part 1 of the study will last around 6 months. For eligible participants, Part 2 will last around 8 months.”In the company’s words, NCT06799247 on ClinicalTrials.gov
Other names
Decartes-08 · CAR-T cells

Other drugs for Myasthaenia Gravis

All 37 drugs for Myasthaenia Gravis

Coming up4

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials6

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 30 Dec 2026 Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis
Phase 2Active, not recruiting 5 Jan 2026 Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
Phase 2Active, not recruiting 1 Dec 2026 Descartes-08 for Patients With Systemic Lupus Erythematosus
Phase 2Recruiting Nov 2027 Descartes-08 in Autoantibody Myositis
Phase 1/2Recruiting Dec 2027 Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Phase 1Terminated 19 Apr 2021 Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Descartes-08

Following is part of Solo: you see every change to Descartes-08 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in